Plexium Revenue and Competitors
Estimated Revenue & Valuation
- Plexium's estimated annual revenue is currently $20.5M per year.
- Plexium's estimated revenue per employee is $201,000
- Plexium's total funding is $165M.
Employee Data
- Plexium has 102 Employees.
- Plexium grew their employee count by -3% last year.
Plexium's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Head Technology Development | Reveal Email/Phone |
3 | EVP, Drug Discovery | Reveal Email/Phone |
4 | VP, Biology | Reveal Email/Phone |
5 | Senior Director Proteomics Platform | Reveal Email/Phone |
6 | Director, Biology | Reveal Email/Phone |
7 | Senior Director, Project Management Office | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director, Software Engineering | Reveal Email/Phone |
10 | Director, Facilities & EHS | Reveal Email/Phone |
Plexium Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 542 | -3% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1634 | -2% | N/A | N/A |
#10 | $10.5M | 48 | 12% | N/A | N/A |
What Is Plexium?
Plexium is a pharmaceutical company developing first-in-class therapeutics by modulating E3 ligases
keywords:N/A
$165M
Total Funding
102
Number of Employees
$20.5M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Plexium News
(Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced that Plexium President & CEO, Percival Barretto...
In the fall, it backed Avilar Therapeutics and two months ago, it helped pour $102 million into Plexium, the startup headed by Astellas vet...
Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board
Plexium, Inc., a San Diego, CA-based biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, completed a $35M financing. The round was led by Lux Capital and Pivotal BioVentures, with participation from The Col ...
San Diego-based Plexium, a biotech startup focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, announced this morning that it has raised $35M in a financing round. The funding is an extension of the company's October 2019 S ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34M | 102 | 7% | N/A |
#2 | $14.8M | 102 | 20% | N/A |
#3 | $12.2M | 102 | -8% | N/A |
#4 | $23.1M | 102 | 4% | N/A |
#5 | $13.6M | 102 | -8% | N/A |